Latest Insider Transactions at Neurocrine Biosciences Inc (NBIX)
This section provides a real-time view of insider transactions for Neurocrine Biosciences Inc (NBIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NEUROCRINE BIOSCIENCES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NEUROCRINE BIOSCIENCES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 02
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.33%
|
$17,200
$43.24 P/Share
|
|
Nov 01
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-25.49%
|
$1,200,000
$120.09 P/Share
|
|
Nov 01
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.31%
|
$430,000
$43.24 P/Share
|
|
Oct 31
2022
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
15,000
-6.86%
|
$1,710,000
$114.76 P/Share
|
|
Oct 31
2022
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.42%
|
$180,000
$12.71 P/Share
|
|
Oct 31
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,295
-30.73%
|
$147,630
$114.12 P/Share
|
|
Oct 27
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,923
-14.41%
|
$566,145
$115.04 P/Share
|
|
Oct 27
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,923
+12.6%
|
$211,689
$43.24 P/Share
|
|
Oct 26
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,077
-14.8%
|
$583,855
$115.02 P/Share
|
|
Oct 26
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,077
+12.89%
|
$218,311
$43.24 P/Share
|
|
Oct 17
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,960
-24.07%
|
$545,600
$110.82 P/Share
|
|
Oct 04
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-25.49%
|
$1,110,000
$111.04 P/Share
|
|
Oct 04
2022
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.31%
|
$430,000
$43.24 P/Share
|
|
Oct 04
2022
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$550,000
$110.54 P/Share
|
|
Oct 03
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,437
-25.43%
|
$152,322
$106.59 P/Share
|
|
Sep 08
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
100
-0.34%
|
-
|
|
Sep 07
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
100
-0.34%
|
-
|
|
Aug 15
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,043
+9.77%
|
$426,279
$53.57 P/Share
|
|
Aug 12
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
21,533
-53.27%
|
$2,260,965
$105.95 P/Share
|
|
Aug 12
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,533
+34.76%
|
$753,655
$35.99 P/Share
|
|
Aug 05
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,816
-10.73%
|
$181,600
$100.0 P/Share
|
|
Jun 27
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
754
-4.27%
|
$75,400
$100.0 P/Share
|
|
May 09
2022
|
Richard F Pops Director |
SELL
Open market or private sale
|
Direct |
15,000
-20.26%
|
$1,140,000
$76.3 P/Share
|
|
May 09
2022
|
Richard F Pops Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+16.85%
|
$90,000
$6.66 P/Share
|
|
Apr 25
2022
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
15,000
-6.71%
|
$1,380,000
$92.76 P/Share
|
|
Apr 25
2022
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.28%
|
$90,000
$6.66 P/Share
|
|
Apr 01
2022
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
10,728
-23.97%
|
$1,008,432
$94.93 P/Share
|
|
Apr 01
2022
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.89%
|
$120,000
$6.66 P/Share
|
|
Mar 22
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,455
-22.34%
|
$803,225
$95.05 P/Share
|
|
Mar 18
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
300
-0.79%
|
$28,500
$95.0 P/Share
|
|
Feb 08
2022
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
980
-4.63%
|
$77,420
$79.65 P/Share
|
|
Feb 08
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
980
-4.6%
|
$77,420
$79.67 P/Share
|
|
Feb 08
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
700
-3.87%
|
$55,300
$79.56 P/Share
|
|
Feb 08
2022
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
980
-0.87%
|
$77,420
$79.67 P/Share
|
|
Feb 08
2022
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,274
-0.49%
|
$179,646
$79.49 P/Share
|
|
Feb 08
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
911
-2.33%
|
$71,969
$79.51 P/Share
|
|
Feb 08
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
701
-3.61%
|
$55,379
$79.53 P/Share
|
|
Feb 08
2022
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
980
-3.83%
|
$77,420
$79.52 P/Share
|
|
Feb 08
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
700
-19.34%
|
$55,300
$79.62 P/Share
|
|
Feb 07
2022
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,310
-8.13%
|
$264,800
$80.79 P/Share
|
|
Feb 07
2022
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,119
-6.94%
|
$329,520
$80.76 P/Share
|
|
Feb 07
2022
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,158
-4.26%
|
$172,640
$80.64 P/Share
|
|
Feb 07
2022
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,900
-1.34%
|
$472,000
$80.76 P/Share
|
|
Feb 07
2022
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,710
-0.63%
|
$696,800
$80.82 P/Share
|
|
Feb 07
2022
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,168
-2.81%
|
$253,440
$80.69 P/Share
|
|
Feb 07
2022
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
2,681
-4.91%
|
$214,480
$80.72 P/Share
|
|
Feb 07
2022
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,744
-5.58%
|
$219,520
$80.79 P/Share
|
|
Feb 07
2022
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
240
-9.48%
|
$19,440
$81.07 P/Share
|
|
Jan 24
2022
|
Stephen A Sherwin Director |
SELL
Open market or private sale
|
Direct |
15,000
-37.45%
|
$1,110,000
$74.43 P/Share
|
|
Jan 24
2022
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+27.25%
|
$90,000
$6.66 P/Share
|